Chemoprevention of skin cancer and photoaging

Clinics in Dermatology

Volumn 22, Issue 3, 2004, Pages 178-182

  Uliasz, Annemarie ^a   Spencer, James M ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; BETA CAROTENE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPAMINE; DICLOFENAC; EFLORNITHINE; ETRETINATE; ISOTRETINOIN; NONSTEROID ANTIINFLAMMATORY AGENT; POLYAMINE DERIVATIVE; SELENIUM; UNCLASSIFIED DRUG; VITAMIN;

CANCER RISK; CARCINOGENESIS; CLINICAL RESEARCH; CLINICAL TRIAL; DIET SUPPLEMENTATION; DNA REPAIR; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; OXIDATIVE STRESS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT WITHDRAWAL; ULTRAVIOLET RADIATION; ULTRAVIOLET SPECTROSCOPY; VITAMIN SUPPLEMENTATION;

EID: 3242713141     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2003.12.012     Document Type: Article

References (34)

1. Weringhaus K., Meydani M., Bhawan J., et al. Evaluation of the photoprotective effect of oral vitamin E supplementation. Arch Dermatol. 130:1994;1257-1261
2. Matther-Roth M.M., Pathak M.A., Parish J., et al. A clinical trial of the effect of oral B-carotene on the response of human skin to solar radiation. J Invest Dermatol. 59:1972;349-353
3. Stahl W., Heinrich U., Jungmann H., et al. Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in tumors. Am J Clin Nutr. 71:2000;797-798
4. Clark L.C., Combs G.F., Turnbull B.W., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA. 276:1996;1957-1963
5. Greenberg E.R., Baron J.A., Stukel T.A., et al. A clinical trial of beta-carotene to prevent basal-cell and squamous-cell cancers of the skin. N Engl J Med. 323:1990;789-795
6. Moon T.E., Levine N., Cartmel B., et al. Effect of retinol in preventing squamous cell cancer in moderate risk subjects a randomized, double-blind, controlled trial. Southwest skin cancer prevention study group. Cancer Epidemiol Biomarkers Prev. 6:1997;949-956
7. Levine N., Moon T.E., Cartmel B., et al. Trial of retinol and isotretinoin in skin cancer prevention a randomized, double-blind, controlled trial. Southwest skin cancer prevention study group. Cancer Epidemiol Biomarkers Prev. 6:1997;957-961
8. Peck G.L., Olsen T.G., Butkus D., et al. Treatment of basal cell carcinoma with 13-cis retinoic acid. Proc Am Assoc Cancer Res. 20:1970;56
9. Kraemer K.H., DiGiovanna J.J., Moshel A.N., et al. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med. 318:1988;1622-1637
10. Baumann C.A., Baron J.A., Stukel T.A., et al. Effects of diet on tumors induced by ultraviolet light. Am J Cancer. 35:1939;213-221
11. Black H.S., Lenger W., Phelps A.W., et al. Influence of dietary lipid upon ultraviolet-light carcinogenesis. Nutr Cancer. 5:1983;59-68
12. Ley R.D., Reeve V.E. Chemoprevention of ultraviolet radiation-induced skin cancer. Environ Health Perspect. 105:1997;981-982
13. Black H.S., Herd J.A., Goldberg L.H., et al. Effect of a low-fat diet on the incidence of actinic keratosis. N Engl J Med. 330:1994;1272-1275
14. Black H.S., Thornby J.I., Wolf J.E. Jr, et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin caner. Int J Cancer. 62:1995;165-169
15. Valcic S., Timmerman B.N., Alberts D.S., et al. Inhibitory effects of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs. 7:1996;461-468
16. Gansler H.L., Timmerman B.N., Malcic S., et al. Prevention of photocarcinogenesis by topical application of pure epigallocatechin gallate isolated from green tea. Nutr Cancer. 26:1996;325-335
17. Wang Z.Y., Huang M.T., Ferrar T., et al. An inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res. 52:1992;1162-1170
18. Zhao J., Wang J., Chen Y., et al. Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanin B5-3'-gallate as the most effective antioxidant constituent. Carcinogenesis. 20:1999;1737-1745
19. Lahiri-Chatterjee M., Katiyar S.K., Mohan R.R., et al. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse tumorigenesis model. Cancer Res. 59:1999;622-632
20. Wei H., Spencer J.M., Gelfand J., et al. The isoflavone genistein a new agent in dermatology? Cosmetic Dermatol. 2:2001;13-19
21. Kang S., Wan Y., Lee J., et al. Isoflavone genistein blocks ultraviolet irradiation-induced epidermal growth factor-receptor activated, mitogen-activated protein kinase activity and matrix metalloproteinase gene expression in human skin in vivo. J Invest Dermatol. 114:2000;153
22. Cheng A.L., Hsu C.H., Lin J.K., et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21:2001;2895-2900
23. Wattenberg L.W. An overview of chemoprevention current status and future prospects. Proc Soc Exp Biol Med. 216:1997;133-141
24. Rioux N., Castonguay A. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. Cancer Res. 58:1998;5354-5360
25. Drago J.R., Al-Mondhiry H.A. The effect of prostaglandin modulators on prostate tumor growth and metastatis. Anticancer Res. 4:1984;391-394
26. Marks F., Furstenberger G. Cancer chemoprevention through interruption of multistage carcinogenesis; the lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer. Eur J Cancer. 36:2000;314-329
27. Athar M., An K.P., Morel K.D., et al. Ultraviolet B (UVB)-induced COX-2 expression in murine skin an immunohistochemical study. Biochem Biophys Res Comm. 280:2001;1042-1047
28. Fischer S.M., Herng-Hsang L., Gordon G.B., et al. Chemopreventative activity of celecoxib, a specific cyclooxygenase 2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogensis. Mol Carcinog. 25:1999;231-240
29. Pentland A.P., Schoggins J.W., Scott G.A., et al. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogen. 20:1999;360-367
30. Orengo I.F., Gerguis J., Phillips R., et al. Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer. Arch Dermatol. 138:2002;751-755
31. Peterson S.R., Goldberg L.H. New and emerging treatments for nonmelanomas and actinic keratoses. J Drugs Dermatol. 2:2002;429-432
32. Stratton S.P., Dorr R.T., Alberts D.S. The state-of-the-art in chemoprevention of skin cancer. Eur J Cancer. 36:2000;1292-1297
33. Alberts D.S., Dorr R.T., Einspar L.G., et al. Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine. Cancer Epidemiol Biomarkers Prev. 9:2000;1281-1286
34. Yarosh D., Klein J., O'Connor A., et al. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in seroderma pigmentosum a randomized study. Lancet. 357:2001;926-929